Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2025)
Propanc Biopharma (PPCB) posted quarterly Long-Term Deferred Tax of $15000.0 for Q3 2025, down 44.68% year-over-year from $27117.0 in Q3 2024, and down 94.86% quarter-over-quarter from $291773.0 in Q2 2025.
Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Long-Term Deferred Tax for 6 consecutive years, with $15000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Long-Term Deferred Tax fell 44.68% year-over-year to $15000.0; the TTM figure through Sep 2025 stood at $15000.0 (down 44.68% YoY), while the FY2025 annual figure was $291773.0, up 975.98% from the prior year.
- Long-Term Deferred Tax slipped to $15000.0 in Q3 2025 per PPCB's latest filing, from $291773.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $291773.0 in Q2 2025 and bottomed at $15000.0 in Q3 2025.
- Historically, Long-Term Deferred Tax has averaged $68155.1 across 4 years, with a median of $27117.0 in 2024.
- On a YoY basis, Long-Term Deferred Tax climbed as much as 975.98% in 2025 and fell as far as 44.68% in 2025.
- Propanc Biopharma's Long-Term Deferred Tax stood at $20000.0 in 2021, then changed by 0.0% to $20000.0 in 2022, then jumped by 160.58% to $52117.0 in 2024, then sank by 71.22% to $15000.0 in 2025.
- Business Quant data shows PPCB's Long-Term Deferred Tax at $15000.0 in Q3 2025, $291773.0 in Q2 2025, and $92117.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 291,773.00 |
| Mar 31, 2025 | 92,117.00 |
| Dec 31, 2024 | 52,117.00 |
| Sep 30, 2024 | 27,117.00 |
| Jun 30, 2024 | 27,117.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2018 | 313,923.00 |
| Jun 30, 2018 | 6.20 Mn |
| Jun 30, 2017 | 61,715.00 |